Cocrystal Pharma Management
Management criteria checks 2/4
Cocrystal Pharma's CEO is Sam Lee, appointed in Jan 2008, has a tenure of 16.83 years. total yearly compensation is $627.20K, comprised of 62.9% salary and 37.1% bonuses, including company stock and options. directly owns 0.55% of the company’s shares, worth €116.73K. The average tenure of the management team and the board of directors is 16.8 years and 5.1 years respectively.
Key information
Sam Lee
Chief executive officer
US$627.2k
Total compensation
| CEO salary percentage | 62.9% |
| CEO tenure | 16.8yrs |
| CEO ownership | 0.6% |
| Management average tenure | 16.8yrs |
| Board average tenure | 5.1yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$19m |
| Jun 30 2024 | n/a | n/a | -US$18m |
| Mar 31 2024 | n/a | n/a | -US$17m |
| Dec 31 2023 | US$627k | US$395k | -US$18m |
| Sep 30 2023 | n/a | n/a | -US$18m |
| Jun 30 2023 | n/a | n/a | -US$20m |
| Mar 31 2023 | n/a | n/a | -US$40m |
| Dec 31 2022 | US$622k | US$371k | -US$39m |
| Sep 30 2022 | n/a | n/a | -US$38m |
| Jun 30 2022 | n/a | n/a | -US$36m |
| Mar 31 2022 | n/a | n/a | -US$16m |
| Dec 31 2021 | US$665k | US$333k | -US$14m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$10m |
| Dec 31 2020 | US$462k | US$293k | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$56m |
| Jun 30 2020 | n/a | n/a | -US$55m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$241k | US$241k | -US$48m |
| Sep 30 2019 | n/a | n/a | -US$45m |
| Jun 30 2019 | n/a | n/a | -US$45m |
| Mar 31 2019 | n/a | n/a | -US$45m |
| Dec 31 2018 | US$412k | US$201k | -US$49m |
| Sep 30 2018 | n/a | n/a | US$435k |
| Jun 30 2018 | n/a | n/a | US$41k |
| Mar 31 2018 | n/a | n/a | US$382k |
| Dec 31 2017 | US$253k | US$253k | -US$613k |
Compensation vs Market: Sam's total compensation ($USD627.20K) is above average for companies of similar size in the German market ($USD472.15K).
Compensation vs Earnings: Sam's compensation has increased whilst the company is unprofitable.
CEO
Sam Lee (64 yo)
16.8yrs
Tenure
US$627,201
Compensation
Dr. Sam Lee, Ph D., Co-founded Cocrystal Pharma, Inc. in 2008 and serves as its President since January 2, 2014 and serves as its Interim Co-Chief Executive Officer since May 2023 and had been its Interim...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.6yrs | US$184.84k | 0.53% € 111.5k | |
| Co-Founder | 16.8yrs | US$627.20k | 0.55% € 116.7k | |
| Co-CEO, CFO & Corporate Secretary | 7.4yrs | US$627.20k | 0.20% € 42.6k |
16.8yrs
Average Tenure
64yo
Average Age
Experienced Management: 8CC's management team is seasoned and experienced (16.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 4.6yrs | US$184.84k | 0.53% € 111.5k | |
| Independent Director | 1.6yrs | US$49.47k | 10.02% € 2.1m | |
| Independent Director | 3.5yrs | US$44.23k | 0.072% € 15.3k | |
| Independent Director | 10.8yrs | US$84.12k | 13.23% € 2.8m | |
| Independent Vice Chairman | 10.8yrs | US$113.51k | 0.11% € 23.7k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 5.6yrs | US$79.97k | 0.073% € 15.5k | |
| Member of Scientific Advisory Board | no data | no data | no data |
5.1yrs
Average Tenure
77yo
Average Age
Experienced Board: 8CC's board of directors are considered experienced (5.1 years average tenure).